Literature DB >> 8308105

Use of a monoclonal antibody in a dot immunobinding assay for detection of a circulating mannoprotein of Candida spp. in neutropenic patients with invasive candidiasis.

F De Bernardis1, C Girmenia, M Boccanera, D Adriani, P Martino, A Cassone.   

Abstract

A dot immunobinding assay for the detection of a circulating mannoprotein (MP) antigen of Candida species in the sera of neutropenic patients in a hematological setting is described. The technique is based on the use of a monoclonal antibody which recognizes an oligomannoside epitope shared by distinct MP of pathogenic Candida species. The sensitivity of the assay for antigen detection in serum was between 2 and 5 ng/ml, and MPs from Candida albicans, Candida tropicalis, Torulopsis glabrata, and Candida parapsilosis, but not Candida krusei, could be detected. A retrospective analysis of sera from patients with proven invasive candidiasis versus sera from controls (Candida-colonized and noncolonized subjects) revealed that the novel assay has sufficient sensitivity, specificity, and predictive values to be of potential diagnostic significance.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8308105      PMCID: PMC266365          DOI: 10.1128/jcm.31.12.3142-3146.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

1.  Candida antigen latex test for detection of invasive candidiasis in immunocompromised patients.

Authors:  M J Ness; W P Vaughan; G L Woods
Journal:  J Infect Dis       Date:  1989-03       Impact factor: 5.226

2.  Monoclonal antibodies against Candida tropicalis mannan: antigen detection by enzyme immunoassay and immunofluorescence.

Authors:  E Reiss; L de Repentigny; R J Kuykendall; A W Carter; R Galindo; P Auger; S L Bragg; L Kaufman
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

3.  Production and characterisation of a monoclonal antibody to a cell-surface, glucomannoprotein constituent of Candida albicans and other pathogenic Candida species.

Authors:  A Cassone; A Torosantucci; M Boccanera; G Pellegrini; C Palma; F Malavasi
Journal:  J Med Microbiol       Date:  1988-12       Impact factor: 2.472

4.  Detection of antibodies and antigenemia in leukemic patients with candidiasis by enzyme-linked immunosorbent assay.

Authors:  K L Meckstroth; E Reiss; J W Keller; L Kaufman
Journal:  J Infect Dis       Date:  1981-07       Impact factor: 5.226

5.  Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy.

Authors:  R Horn; B Wong; T E Kiehn; D Armstrong
Journal:  Rev Infect Dis       Date:  1985 Sep-Oct

6.  Proliferation of human peripheral blood mononuclear cells induced by Candida albicans and its cell wall fractions.

Authors:  C M Ausiello; G C Spagnoli; M Boccanera; I Casalinuovo; F Malavasi; C U Casciani; A Cassone
Journal:  J Med Microbiol       Date:  1986-11       Impact factor: 2.472

7.  Diagnosis of invasive candidiasis by a dot immunobinding assay for Candida antigen detection.

Authors:  A C Reboli
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

8.  Identification and molecular weight characterization of antigens from Candida albicans that are recognized by human sera.

Authors:  N A Strockbine; M T Largen; S M Zweibel; H R Buckley
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

9.  Diagnosis of systemic candidiasis by an enzyme-linked dot immunobinding assay for a circulating immunodominant 47-kilodalton antigen.

Authors:  R Matthews; J Burnie
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

10.  Diagnosis of systemic candidiasis by latex agglutination for serum antigen.

Authors:  J W Bailey; E Sada; C Brass; J E Bennett
Journal:  J Clin Microbiol       Date:  1985-05       Impact factor: 5.948

View more
  8 in total

1.  Production, characterization, and epitope mapping of a monoclonal antibody against aspartic proteinase of Candida albicans.

Authors:  B K Na; G T Chung; C Y Song
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  Use of monoclonal antibody in diagnosis of candidiasis caused by Candida albicans: detection of circulating aspartyl proteinase antigen.

Authors:  B K Na; C Y Song
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

3.  Clinical and mycological evaluation of fluconazole in the secondary prophylaxis of esophageal candidiasis in AIDS patients. An open, multicenter study.

Authors:  M G Agresti; F de Bernardis; F Mondello; R Bellocco; G P Carosi; R M Caputo; F Milazzo; F Chiodo; V Giannini; L Minoli
Journal:  Eur J Epidemiol       Date:  1994-02       Impact factor: 8.082

4.  Clearances of Candida albicans-derived alpha- and beta-linked mannose residues in sera from patients with candidiasis.

Authors:  D Poulain; R Robert; F Mesnard; B Sendid; G Lepage; D Camus
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-01       Impact factor: 3.267

5.  Assessment of detection of Candida mannoproteinemia as a method to differentiate central venous catheter-related candidemia from invasive disease.

Authors:  C Girmenia; P Martino; F De Bernardis; A Cassone
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

6.  Detection of cell wall mannoprotein Mp1p in culture supernatants of Penicillium marneffei and in sera of penicilliosis patients.

Authors:  L Cao; K M Chan; D Chen; N Vanittanakom; C Lee; C M Chan; T Sirisanthana; D N Tsang; K Y Yuen
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

7.  New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: useful combined test for diagnosis of systemic candidiasis.

Authors:  B Sendid; M Tabouret; J L Poirot; D Mathieu; J Fruit; D Poulain
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

Review 8.  Current status of nonculture methods for diagnosis of invasive fungal infections.

Authors:  Siew Fah Yeo; Brian Wong
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.